These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The assessment of -adrenoceptor blocking potency and cardioselectivity in vitro and in vivo. Baird JR; Linnell J J Pharm Pharmacol; 1972 Nov; 24(11):880-5. PubMed ID: 4405651 [No Abstract] [Full Text] [Related]
4. [Interrelation between the alpha- and beta-receptor activating actions of catecholamines in the tracheal muscle]. Takeshi O Nihon Heikatsukin Gakkai Zasshi; 1969 Sep; 5(3):170-5. PubMed ID: 4402685 [No Abstract] [Full Text] [Related]
5. [Analysis of the concentration-effect curves for the action of isoproterenol on the trachea of guinea pigs pretreated with beta-adrenergic blocking agents]. Otorii T Nihon Heikatsukin Gakkai Zasshi; 1969 Jun; 5(2):76-83. PubMed ID: 4402317 [No Abstract] [Full Text] [Related]
6. Pharmacological studies on 1-(7-indenyloxy)-3-isopropylaminopropan-2-Ol hydrochloride (YB-2), a new -adrenergic blocking agent. Tachikawa S; Takenaka T Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):79-92. PubMed ID: 4144371 [No Abstract] [Full Text] [Related]
7. Beta-adrenergic receptors in various organs. Takagi K; Takayanagi I Jpn J Pharmacol; 1970 Mar; 20(1):92-101. PubMed ID: 4393818 [No Abstract] [Full Text] [Related]
9. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig. Horii D; Kawada T; Takeda K; Imai S Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764 [No Abstract] [Full Text] [Related]
10. Beta-adrenolytic, antiarrhythmic and local anaesthetic effects of phenylephrine. Reinhardt D; Wagner J Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(3):245-61. PubMed ID: 4154414 [No Abstract] [Full Text] [Related]
11. [Stimulation of adrenergic beta-receptors in the heart of normal and reserpinized guinea pigs by oxyfedrine]. Kukovetz WR; Pöch G Arzneimittelforschung; 1969 Sep; 19(9):1562-6. PubMed ID: 5394533 [No Abstract] [Full Text] [Related]
12. Effects of oxyfedrine on isolated portal vein and other smooth muscles. Mackenzie JE; Parratt JR Br J Pharmacol; 1973 Apr; 47(4):827-37. PubMed ID: 4146743 [TBL] [Abstract][Full Text] [Related]
13. Changes in beta-adrenoceptor-blocking activity produced by chemical modifications in the practolol molecule. Weinstock M; Schechter Y; Erez M; Shtacher G Eur J Pharmacol; 1974 May; 26(2):191-7. PubMed ID: 4152806 [No Abstract] [Full Text] [Related]
16. An investigation of the long duration of action of oxyfedrine. Beckett PR; Foster RW Eur J Pharmacol; 1973 Jan; 21(1):11-20. PubMed ID: 4709197 [No Abstract] [Full Text] [Related]
17. Beta-adrenergic receptor blocking properties of three allyl-substituted phenoxypropanolamines. Ablad B; Brogård M; Carlsson E; Ek L Eur J Pharmacol; 1970; 13(1):59-64. PubMed ID: 4395676 [No Abstract] [Full Text] [Related]
18. The cardioactive and related properties of N-methyl-N-( -phenylethyl)-1,2,3,4-tetrahydro-6-methoxy-4,4-dimethyl-2-naphthylamine hydrochloride (2-AT-1). Graeff DM; Johnson WE; Martin AR Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):134-48. PubMed ID: 4398737 [No Abstract] [Full Text] [Related]
19. The beta-blocking potency and cardioselectivity of tolamolol and its isomers in rodents. Adam KR; Baird JR; Burges RA; Linnell J Eur J Pharmacol; 1974 Feb; 25(2):170-5. PubMed ID: 4154851 [No Abstract] [Full Text] [Related]
20. Interaction of isoprenaline and beta-adrenoceptor blocking drugs on intestinal smooth muscle. Farmer JB; Levy GP Br J Pharmacol; 1970 Sep; 40(1):154P-155P. PubMed ID: 4395085 [No Abstract] [Full Text] [Related] [Next] [New Search]